University home

Library

Current students

Staff intranet

Give

Lambert Initiative for Cannabinoid Therapeutics

The Lambert Initiative researchers with former premier Mike Baird and Vice Chancellor Michael Spence

News_

News highlights

Medicinal cannabis news from around the world

Update: From September 2019, we will be now be sharing the latest medicinal cannabis news and views via our Twitter account and will no longer be updating this page and distributing the Lambert Initiative weekly news digest.

Connect with us

Lambert Initiative in the news

05 October 2021

'Mother of all cannabinoids': anti-seizure compounds found in cannabis

The team at the Lambert Initiative for Cannabinoid Therapeutics is focused on developing a better cannabis-based treatment for Dravet syndrome, an intractable form of childhood epilepsy.

View

New Research on THC-Impaired Driving Shows Not All Skills Affected Equally by Cannabis

Patients prescribed CBD-only medications are unlikely to test positive for THC during random roadside drug testing, our research has found.

View

When drugs collide

Dr Lyndsey Anderson discusses her research on cannabinoids interacting with conventional medications in The Cannabis Scientist

View

22 July 2021

'An entourage effect': new clues on how low-dose CBD products work

Research from the Lambert Initiative for Cannabinoid Therapeutics shows that hemp extracts deliver high concentrations of cannabinoid acids in mice due to a 'pharmacokinetic entourage' mechanism.

View

Diagram showing how CBDA cannabinoid acids interact in the bloodstream.

Researchers secure funding to assess medicinal cannabis for children with advanced cancer

Researchers have received almost $700,000 from the Medical Research Future Fund (MRFF) to assess the effectiveness, safe dosage and side-effects of two medicinal cannabis products for managing symptoms in children with advanced cancer.

View

Survey: Pharmacists, Are you ready for low-dose cannabidiol products?

Researchers from the Lambert Initiative for Cannabinoid Therapeutics and the Sydney Pharmacy School at the University of Sydney are surveying pharmacists to identify attitudes towards, experiences with and education level on prescription medicinal cannabis and low-dose CBD.

View

New research reveals how long it takes for cannabis impairment to subside - ABC News

11 April 2021. New research has shown for the first time how long cannabis users are likely to be impaired and when it may be safe for them to drive.

View

Call to reform drug driving laws as study shows impairment lasts hours - Sydney Morning Herald

11 April 2021. Researchers at the University of Sydney say drug driving laws are “out of date” and should reflect the results of a new study that found impairment after taking cannabis lasted about three to 10 hours

View

Medicinal cannabis blacklisted by Australian pain specialists - Sydney Morning Herald

23 March 2021. “Let’s give medicinal cannabis the benefit of the doubt while the hundreds of clinical trials around the world build the evidence base for their use.” Prof McGregor provides a rationale to challenge the ANZCA''s rejection of medicinal cannabis.

View

News archive

From trialling medicinal cannabis in the treatment of paediatric epilepsy and cancer to a donation that has put Australia at the forefront of medicinal cannabis research, read all the latest news from the Lambert Initiative.

News_

Media mentions

We are regularly engaged in wider public discussion around medicinal cannabis, current research and its use.

Publications

The Lambert Initiative are leaders in the field of medicinal cannabinoids. Our work is regularly cited in peer-reviewed publications in scientific literature.

Presentations and outreach

Researchers from the Lambert Initiative are always looking for opportunities to share our work with fellow researchers and the interested public. From symposiums to public events and festivals, we've shared the highlights of our work across a broad range of topics.

'Mother of all cannabinoids': anti-seizure compounds found in cannabis

New Research on THC-Impaired Driving Shows Not All Skills Affected Equally by Cannabis

When drugs collide

'An entourage effect': new clues on how low-dose CBD products work

Researchers secure funding to assess medicinal cannabis for children with advanced cancer

Survey: Pharmacists, Are you ready for low-dose cannabidiol products?

New research reveals how long it takes for cannabis impairment to subside - ABC News

Call to reform drug driving laws as study shows impairment lasts hours - Sydney Morning Herald

Medicinal cannabis blacklisted by Australian pain specialists - Sydney Morning Herald

Medicinal cannabis: where are we?

Medicinal cannabis for IBD survey one of top articles for 2020

Can cannabis be used to treat childhood epilepsy?

Guide to prescribing medicinal cannabis top article for 2020

Cannabidiol (CBD) in cannabis does not impair driving, landmark study shows

Why more people are turning to medicinal cannabis

Has legalising medicinal cannabis made a difference?

Australia unprepared for over-the-counter medical cannabis sales

Over-the-counter medicinal cannabis plan not what it seems, experts warn

Medical cannabis study for spinal injury pain wins NSW Health funding

How Australians use medical cannabis since legislation: new survey

News archive

Media mentions

Publications

Presentations and outreach

Media

Student links

About us

Connect